286 related articles for article (PubMed ID: 36275683)
21. Action of substance P and PAMP(9-20) on different excitation sites of MRGPRX2 induces differences in mast cell activation.
Che D; Zheng Y; Hou Y; Du X; Jia T; Zhao Q; Song X; Zhou T; Geng S
Int Immunopharmacol; 2021 Dec; 101(Pt B):108342. PubMed ID: 34753104
[TBL] [Abstract][Full Text] [Related]
22. Differential Regulation of Mas-Related G Protein-Coupled Receptor X2-Mediated Mast Cell Degranulation by Antimicrobial Host Defense Peptides and Porphyromonas gingivalis Lipopolysaccharide.
Gupta K; Idahosa C; Roy S; Lee D; Subramanian H; Dhingra A; Boesze-Battaglia K; Korostoff J; Ali H
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28694291
[No Abstract] [Full Text] [Related]
23. Thimerosal induces skin pseudo-allergic reaction via Mas-related G-protein coupled receptor B2.
Peng B; Che D; Hao Y; Zheng Y; Liu R; Qian Y; Cao J; Wang J; Zhang Y; He L; Geng S
J Dermatol Sci; 2019 Sep; 95(3):99-106. PubMed ID: 31558225
[TBL] [Abstract][Full Text] [Related]
24. Substance P analogs devoid of key residues fail to activate human mast cells
Raj S; Hlushak S; Arizmendi N; Kovalenko A; Kulka M
Front Immunol; 2023; 14():1155740. PubMed ID: 37228611
[TBL] [Abstract][Full Text] [Related]
25. Revisiting the role of MRGPRX2 on hypersensitivity reactions to neuromuscular blocking drugs.
Ali H
Curr Opin Immunol; 2021 Oct; 72():65-71. PubMed ID: 33857758
[TBL] [Abstract][Full Text] [Related]
26. MRGPRX2 activation in mast cells by neuromuscular blocking agents and other agonists: Modulation by sugammadex.
Fernandopulle NA; Zhang SS; Soeding PF; Mackay GA
Clin Exp Allergy; 2021 May; 51(5):685-695. PubMed ID: 33275825
[TBL] [Abstract][Full Text] [Related]
27. Lactic acid suppresses MRGPRX2 mediated mast cell responses.
Syed M; Kammala AK; Callahan B; Oskeritzian CA; Subramanian H
Cell Immunol; 2021 Oct; 368():104422. PubMed ID: 34399172
[TBL] [Abstract][Full Text] [Related]
28. Mast cell degranulation via MRGPRX2 by isolated human albumin fragments.
Karhu T; Akiyama K; Vuolteenaho O; Bergmann U; Naito T; Tatemoto K; Herzig KH
Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2530-2534. PubMed ID: 28844982
[TBL] [Abstract][Full Text] [Related]
29. Amelioration of Compound 48/80-Mediated Itch and LL-37-Induced Inflammation by a Single-Stranded Oligonucleotide.
Dondalska A; Rönnberg E; Ma H; Pålsson SA; Magnusdottir E; Gao T; Adam L; Lerner EA; Nilsson G; Lagerström M; Spetz AL
Front Immunol; 2020; 11():559589. PubMed ID: 33101278
[TBL] [Abstract][Full Text] [Related]
30. MRGPRX2 signals its importance in cutaneous mast cell biology: Does MRGPRX2 connect mast cells and atopic dermatitis?
Wang Z; Babina M
Exp Dermatol; 2020 Nov; 29(11):1104-1111. PubMed ID: 32866307
[TBL] [Abstract][Full Text] [Related]
31. MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia.
Navinés-Ferrer A; Serrano-Candelas E; Lafuente A; Muñoz-Cano R; Martín M; Gastaminza G
Sci Rep; 2018 Aug; 8(1):11628. PubMed ID: 30072729
[TBL] [Abstract][Full Text] [Related]
32. MRGPRX2-Mediated Degranulation of Human Skin Mast Cells Requires the Operation of G
Wang Z; Franke K; Bal G; Li Z; Zuberbier T; Babina M
Cells; 2022 Mar; 11(6):. PubMed ID: 35326404
[TBL] [Abstract][Full Text] [Related]
33. MRGPRX2 and Immediate Drug Hypersensitivity: Insights From Cultured Human Mast Cells.
Elst J; Sabato V; Faber MA; Bridts CH; Mertens C; Van Houdt M; Van Gasse AL; Hagendorens MM; Van Tendeloo V; Maurer M; Campillo-Davo D; Timmermans JP; Pintelon I; Ebo DG
J Investig Allergol Clin Immunol; 2021 Dec; 31(6):489-499. PubMed ID: 32732181
[TBL] [Abstract][Full Text] [Related]
34. Small-Molecule Host-Defense Peptide Mimetic Antibacterial and Antifungal Agents Activate Human and Mouse Mast Cells via Mas-Related GPCRs.
Alkanfari I; Freeman KB; Roy S; Jahan T; Scott RW; Ali H
Cells; 2019 Apr; 8(4):. PubMed ID: 30987258
[TBL] [Abstract][Full Text] [Related]
35. Authentic and Ectopically Expressed MRGPRX2 Elicit Similar Mechanisms to Stimulate Degranulation of Mast Cells.
Lazki-Hagenbach P; Ali H; Sagi-Eisenberg R
Cells; 2021 Feb; 10(2):. PubMed ID: 33673037
[TBL] [Abstract][Full Text] [Related]
36. Thymic Stromal Lymphopoietin Promotes MRGPRX2-Triggered Degranulation of Skin Mast Cells in a STAT5-Dependent Manner with Further Support from JNK.
Babina M; Wang Z; Franke K; Zuberbier T
Cells; 2021 Jan; 10(1):. PubMed ID: 33429916
[TBL] [Abstract][Full Text] [Related]
37. Rocuronium Hypersensitivity: Does Off-Target Occupation of the MRGPRX2 Receptor Play a Role?
Van Gasse AL; Elst J; Bridts CH; Mertens C; Faber M; Hagendorens MM; De Clerck LS; Sabato V; Ebo DG
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):998-1003. PubMed ID: 30315997
[TBL] [Abstract][Full Text] [Related]
38. IL-33 and MRGPRX2-Triggered Activation of Human Skin Mast Cells-Elimination of Receptor Expression on Chronic Exposure, but Reinforced Degranulation on Acute Priming.
Wang Z; Guhl S; Franke K; Artuc M; Zuberbier T; Babina M
Cells; 2019 Apr; 8(4):. PubMed ID: 30979016
[TBL] [Abstract][Full Text] [Related]
39. Mas-Related G Protein-Coupled Receptor-X2 (MRGPRX2) in Drug Hypersensitivity Reactions.
Porebski G; Kwiecien K; Pawica M; Kwitniewski M
Front Immunol; 2018; 9():3027. PubMed ID: 30619367
[TBL] [Abstract][Full Text] [Related]
40. Emerging Roles for MAS-Related G Protein-Coupled Receptor-X2 in Host Defense Peptide, Opioid, and Neuropeptide-Mediated Inflammatory Reactions.
Ali H
Adv Immunol; 2017; 136():123-162. PubMed ID: 28950944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
